Literature DB >> 12692689

Positron emission tomography in the management of lymphomas: a summary.

M J O'Doherty1, P J Hoskin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12692689     DOI： 10.1007/s00259-003-1170-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  23 in total

1.  Sense, antisense, and common sense.

Authors:  J L Urbain
Journal:  J Nucl Med       Date:  2001-11       Impact factor: 10.057

Review 2.  Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  Sarah J Vinnicombe; Rodney H Reznek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-23       Impact factor: 9.236

Review 3.  Impact of technology on the utilisation of positron emission tomography in lymphoma: current and future perspectives.

Authors:  D Visvikis; P J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-13       Impact factor: 9.236

4.  Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans.

Authors:  Gerald Antoch; Lutz S Freudenberg; Thomas Egelhof; Jörg Stattaus; Walter Jentzen; Jörg F Debatin; Andreas Bockisch
Journal:  J Nucl Med       Date:  2002-10       Impact factor: 10.057

Review 5.  Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma.

Authors:  Einat Even-Sapir; Ora Israel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-18       Impact factor: 9.236

Review 6.  Imaging methods in gene therapy of cancer.

Authors:  U Haberkorn; A Altmann
Journal:  Curr Gene Ther       Date:  2001-07       Impact factor: 4.391

7.  Rapid synthesis of a 5'-fluorinated oligodeoxy-nucleotide: a model antisense probe for use in imaging with positron emission tomography (PET).

Authors:  D Pan; S S Gambhir; T Toyokuni; M R Iyer; N Acharya; M E Phelps; J R Barrio
Journal:  Bioorg Med Chem Lett       Date:  1998-06-02       Impact factor: 2.823

8.  Positron emission tomography in the management of lymphomas.

Authors:  M J O'Doherty; E A Macdonald; S F Barrington; N G Mikhaeel; S Schey
Journal:  Clin Oncol (R Coll Radiol)       Date:  2002-10       Impact factor: 4.126

9.  PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients.

Authors:  C Burger; G Goerres; S Schoenes; A Buck; A H R Lonn; G K Von Schulthess
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-04-19       Impact factor: 9.236

10.  PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images.

Authors:  Yuji Nakamoto; Medhat Osman; Christian Cohade; Laura T Marshall; Jonathan M Links; Steve Kohlmyer; Richard L Wahl
Journal:  J Nucl Med       Date:  2002-09       Impact factor: 10.057
View more
  1 in total

1.  18F-FDG PET in malignant lymphoma: significance of positive findings.

Authors:  Paolo Castellucci; PierLuigi Zinzani; Michael Pourdehnad; Lapo Alinari; Cristina Nanni; Mohsen Farsad; Giuseppe Battista; Monica Tani; Vittorio Stefoni; Romeo Canini; Nino Monetti; Domenico Rubello; Abass Alavi; Roberto Franchi; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-23       Impact factor: 9.236
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.